Showing results (1451-1460 of 2,287) with videos related to

Sort By:
Pageof 229
HIV Medicine|August 30, 2008
The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patientsC J P van den Bout-van den Beukel, M van den Bos, W J G Oyen, et al.
HIV Medicine|August 30, 2008
The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART eraM D Burkey, L E Wilson, R D Moore, et al.
HIV Medicine|March 14, 2007
Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programmeE Wood, R S Hogg, B Yip, et al.
HIV Medicine|March 14, 2007
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or deathC Holkmann Olsen, A Mocroft, O Kirk, et al.
HIV Medicine|March 14, 2007
Pharmacokinetic interaction between rifampicin and ritonavir-boosted atazanavir in HIV-infected patientsJ Mallolas, M Sarasa, M Nomdedeu, et al.
HIV Medicine|June 15, 2007
Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study TeamF T Aweeka, M Kang, J-Y Yu, et al.
HIV Medicine|June 15, 2007
Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDSJ S Josephs, J A Fleishman, P Gaist, et al.
HIV Medicine|June 15, 2007
Malignancies in HIV-infected Thai patientsS Kiertiburanakul, S Likhitpongwit, S Ratanasiri, et al.
HIV Medicine|September 1, 2007
The long-term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model-based approachY Yazdanpanah, M Vray, J Meynard, et al.
HIV Medicine|October 20, 2007
Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factorsM K Jain, C Aragaki, L Fischbach, et al.
Pageof 229